Typicality: | 0.507 |
Saliency: | 0.223 |
with respect to pulmonary safety | 3 | other |
with f3 fibrosis | 2 | other |
with atherosclerotic disease | 2 | other |
trial → target → patient | 9 |
trial → select → patient | 3 |
negative | neutral | positive |
0.210 | 0.569 | 0.221 |
Raw frequency | 12 |
Normalized frequency | 0.223 |
Modifier score | 1.000 |
Perplexity | 469.176 |